How to help your patients find Delestrogen in stock: A provider's guide

Helping Your Patients Find Delestrogen: A Provider's Toolkit

Your patients are coming to you frustrated. They can't find Delestrogen (Estradiol Valerate injection) at their pharmacy, and they need your help. As a prescriber, you have several tools at your disposal to improve their chances of getting their medication — even during an active shortage.

This guide covers practical, actionable strategies you can implement today.

Understanding the Current Landscape

Delestrogen and generic Estradiol Valerate injection have experienced intermittent shortages since 2016. As of 2026, supply remains inconsistent across the U.S. The shortage disproportionately impacts:

• Transgender patients on feminizing hormone therapy
• Menopausal patients dependent on injectable estrogen
• Patients in rural or underserved areas with limited pharmacy access
• Uninsured or underinsured patients with fewer pharmacy options

Your role extends beyond prescribing — helping patients navigate the supply chain can be the difference between treatment continuity and a dangerous gap in care.

Strategy 1: Optimize Your Prescriptions

Write for Generic

Always write prescriptions for "Estradiol Valerate injection" rather than brand-name "Delestrogen" unless there's a specific clinical reason for brand. This allows pharmacists to fill with any available manufacturer's product, significantly increasing the chances of finding stock.

Authorize Multiple Concentrations

Delestrogen comes in 10 mg/mL, 20 mg/mL, and 40 mg/mL. If you typically prescribe 20 mg/mL, consider also authorizing 40 mg/mL at half the volume (or 10 mg/mL at double the volume). You can do this by:

• Writing the prescription as a total dose (e.g., "Estradiol Valerate 10 mg IM every 2 weeks") rather than a specific concentration and volume
• Adding a note: "May substitute any available concentration with appropriate volume adjustment"
• Providing the patient with a dosing card that shows equivalent volumes for each concentration

Enable 90-Day Fills

When supply is available, help patients stock up by writing for 90-day supplies when insurance allows. This provides a buffer against future shortages.

Prepare Backup Prescriptions

Consider writing a secondary prescription for an alternative (e.g., Estradiol Cypionate compounded, or estradiol patches) that the patient can fill only if their primary medication is unavailable. Document the contingency plan clearly.

Strategy 2: Leverage Pharmacy Networks

Specialty Pharmacies

Specialty pharmacies often maintain dedicated stock of hormonal injectables. If your practice doesn't already have relationships with specialty pharmacies, consider establishing them. Many specialty pharmacies can ship directly to patients.

Compounding Pharmacies

PCAB-accredited compounding pharmacies and FDA-registered 503B outsourcing facilities can prepare Estradiol Valerate or Estradiol Cypionate injections. Key considerations:

• Prescriptions must specify "compounded" — a standard Delestrogen prescription cannot be filled by a compounding pharmacy
• Insurance coverage varies; prepare patients for potential out-of-pocket costs
• Maintain a list of vetted compounding pharmacies you can recommend
• 503B facilities can produce larger batches and may have more reliable supply

Hospital and Clinic Dispensing

If your practice or health system has an in-house pharmacy or clinic dispensing program, explore whether you can stock Estradiol Valerate injection. This can be especially valuable for clinics that see high volumes of HRT patients.

Strategy 3: Direct Patients to Availability Tools

MedFinder

Direct patients to MedFinder, a free tool that helps patients find pharmacies with hard-to-get medications in stock. Patients can search by medication name and zip code to identify nearby pharmacies with availability.

Consider adding a reference to MedFinder in your patient education materials or after-visit summaries for patients on medications prone to shortages.

Pharmacy Call Lists

Prepare a handout with local pharmacy phone numbers — including independent, specialty, and compounding pharmacies — that patients can call to check stock. Organized by type:

1. Chain pharmacies (CVS, Walgreens, Rite Aid)
2. Independent pharmacies in your area
3. Specialty pharmacies (local and mail-order)
4. Compounding pharmacies (PCAB-accredited)

Strategy 4: Proactive Patient Communication

At Every Visit

For patients currently on Delestrogen or generic Estradiol Valerate injection:

• Ask about their pharmacy experience — are they having trouble filling?
• Review their current supply level
• Confirm their pharmacy is set up to fill generics
• Update the contingency plan if needed

Between Visits

Use patient portal messages or your EHR's outreach tools to proactively notify patients when you learn about supply changes. A brief message like "We've heard Estradiol Valerate is back in stock at [pharmacy] — you may want to refill early" can make a significant difference.

Staff Training

Train your nursing and front desk staff to:

• Recognize when patients call about medication availability issues
• Provide the pharmacy call list and MedFinder reference
• Escalate to a prescriber when a patient needs a new prescription for an alternative
• Help patients understand that generic Estradiol Valerate is equivalent to Delestrogen

Strategy 5: Dosing Conversions for Alternatives

When switching patients to alternatives, use these evidence-based conversion guidelines:

Estradiol Valerate → Estradiol Cypionate

• Reduce dose by approximately 20-30%
• Maintain the same injection interval initially
• Check serum estradiol at 4-8 weeks and titrate
• Example: Estradiol Valerate 20 mg q2 weeks → Estradiol Cypionate ~5 mg q2 weeks

Estradiol Valerate → Transdermal Patch

• Estradiol Valerate 10 mg q4 weeks ≈ Estradiol patch 0.05-0.075 mg/day
• Estradiol Valerate 20 mg q4 weeks ≈ Estradiol patch 0.1 mg/day
• Monitor and adjust based on clinical response and hormone levels

Estradiol Valerate → Oral Estradiol

• Consider thrombotic risk before switching — oral route increases VTE risk
• Estradiol Valerate 10 mg q4 weeks ≈ Oral estradiol 1-2 mg daily
• Sublingual administration partially mitigates first-pass metabolism
• Best used as temporary bridge during shortage periods

Strategy 6: Reporting and Advocacy

Your reports matter. Help drive systemic solutions by:

• Reporting shortage impacts to the FDA Drug Shortage Staff: drugshortages@fda.hhs.gov
• Submitting reports to ASHP's drug shortage resource center
• Engaging with your professional society's advocacy efforts around drug shortage policy
• Documenting the clinical impact of the shortage in patient records (this data can support future advocacy)

Quick Reference Resources

• MedFinder for Providers — Patient medication availability tool
• Delestrogen shortage: Clinical update for 2026
• How to help patients save money on Delestrogen
• Alternatives to Delestrogen (patient-facing — share with patients)
• ASHP Drug Shortage Resource Center: ashp.org/drug-shortages
• FDA Drug Shortage Database: accessdata.fda.gov/scripts/drugshortages